These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21734256)

  • 21. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
    J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers.
    Murphy SE; von Weymarn LB; Parenteau M; Stepanov I; Tiirikainen M; LeMarchand L; Park SL
    Chem Res Toxicol; 2018 Mar; 31(3):168-175. PubMed ID: 29460622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of tobacco-derived compounds in human pancreatic juice.
    Prokopczyk B; Hoffmann D; Bologna M; Cunningham AJ; Trushin N; Akerkar S; Boyiri T; Amin S; Desai D; Colosimo S; Pittman B; Leder G; Ramadani M; Henne-Bruns D; Beger HG; El-Bayoumy K
    Chem Res Toxicol; 2002 May; 15(5):677-85. PubMed ID: 12018989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
    Yuan JM; Gao YT; Murphy SE; Carmella SG; Wang R; Zhong Y; Moy KA; Davis AB; Tao L; Chen M; Han S; Nelson HH; Yu MC; Hecht SS
    Cancer Res; 2011 Nov; 71(21):6749-57. PubMed ID: 22028322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
    Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
    Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.
    Khariwala SS; Carmella SG; Stepanov I; Bandyopadhyay D; Nelson HH; Yueh B; Hatsukami DK; Hecht SS
    Laryngoscope; 2015 Aug; 125(8):1844-8. PubMed ID: 25877866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.
    Park SL; Carmella SG; Ming X; Vielguth E; Stram DO; Le Marchand L; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):561-9. PubMed ID: 25542827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
    Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
    Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.
    Yuan JM; Butler LM; Stepanov I; Hecht SS
    Cancer Res; 2014 Jan; 74(2):401-11. PubMed ID: 24408916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
    Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
    Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.
    Tulunay OE; Hecht SS; Carmella SG; Zhang Y; Lemmonds C; Murphy S; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1283-6. PubMed ID: 15894687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
    Stepanov I; Upadhyaya P; Carmella SG; Feuer R; Jensen J; Hatsukami DK; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1764-73. PubMed ID: 18628430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.